OrbiMed’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$44.7M Buy
427,900
+41,200
+11% +$4.3M 1.12% 27
2025
Q1
$45.1M Buy
+386,700
New +$45.1M 1.08% 27
2021
Q2
Hold
0
158
2021
Q1
Hold
0
159